Literature DB >> 6727276

Adult hypophosphatasia without apparent skeletal disease: "odontohypophosphatasia" in four heterozygote members of a family.

F Eberle, S Hartenfels, H Pralle, A Käbisch.   

Abstract

Twenty members of a family with adult hypophosphatasia were examined clinically and biochemically. Severe caries causing early loss of permanent teeth was the only clinical symptom which could be attributed to hypophosphatasia. None of them had a history of defective bone mineralization, rachitic skeletal alterations, and recurrent pseudofractures or fractures. An iliac crest bone biopsy of the proposita showed a normal finding corresponding to the age of the patient. Four family members in two subsequent generations were affected, thus suggesting an autosomal dominant inheritance. Their serum and leukocyte alkaline phosphatases were reduced. The phosphoethanolamine (PEA) excretion in the urine was increased to a level which suggests a heterozygote state. The serum alkaline phosphatase activity could be ascribed to the liver isoenzyme fraction. This was shown by polyacrylamide electrophoresis, by inhibition studies with organ-specific inhibitors, heat inactivation, inhibition by antibodies, and treatment with neuraminidase. The proposita had an unexplained, diffuse fatty infiltration of the liver. Thus, not only alterations of bone but also of liver metabolism in hypophosphatasia should be considered. The variety of adult hypophosphatasia described in this paper is characterized by the lack of severe bone abnormalities, the apparently autosomal dominant inheritance, and the reduction of bone and intestinal isoenzyme in the serum. Our study suggests that hypophosphatasia is a heterogeneous disorder which includes both severe and clinically mild forms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6727276     DOI: 10.1007/BF01716257

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  35 in total

1.  Genetic, clinical, biochemical, and pathological features of hypophosphatasia; based on the study of a family.

Authors:  A M BARRETT; D V FAIRWEATHER; R A MCCANCE; A B MORRISON
Journal:  Q J Med       Date:  1956-10

2.  Hypophosphatasia in an adult.

Authors:  O M Jardon; D W Burney; R L Fink
Journal:  J Bone Joint Surg Am       Date:  1970-10       Impact factor: 5.284

3.  Intestinal alkaline phosphatase activity in familial hypophosphatasia.

Authors:  S H Danovitch; P N Baer; L Laster
Journal:  N Engl J Med       Date:  1968-06-06       Impact factor: 91.245

4.  Hypophosphatasia: genetic and dental studies.

Authors:  B Pimstone; E Eisenberg; S Silverman
Journal:  Ann Intern Med       Date:  1966-10       Impact factor: 25.391

5.  Hypophosphatasia: screening and family investigations in an endogamous Hungarian village.

Authors:  K Méhes; L Klujber; G Lassu; P Kajtár
Journal:  Clin Genet       Date:  1972       Impact factor: 4.438

6.  Childhood hypophosphatasia with oral manifestations.

Authors:  J R Jedrychowski; D Duperon
Journal:  J Oral Med       Date:  1979 Jan-Mar

7.  Orthopaedic problems in adult hypophosphatasia: a report of two cases.

Authors:  J M Anderton
Journal:  J Bone Joint Surg Br       Date:  1979-02

8.  [Hypophosphatasia in an adult, with late clinical manifestations (author's transl)].

Authors:  J B Paolaggi; C Job; M Durigon; R Alterescu; L Auquier
Journal:  Nouv Presse Med       Date:  1978-12-30

9.  Hypophosphatasia (adult form): quantitation of serum alkaline phosphatase isoenzyme activity in a large kindred.

Authors:  J L Millán; M P Whyte; L V Avioli; W H Fishman
Journal:  Clin Chem       Date:  1980-06       Impact factor: 8.327

10.  Heterogeneity of adult hypophosphatasia. Report of severe and mild cases.

Authors:  R S Weinstein; M P Whyte
Journal:  Arch Intern Med       Date:  1981-05
View more
  9 in total

1.  Clinical utility gene card for: hypophosphatasia.

Authors:  Etienne Mornet; Christine Beck; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2010-10-27       Impact factor: 4.246

2.  Clinical utility gene card for: hypophosphatasia - update 2013.

Authors:  Etienne Mornet; Christine Hofmann; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

3.  Genetic analysis of adults heterozygous for ALPL mutations.

Authors:  Agnès Taillandier; Christelle Domingues; Annika Dufour; Françoise Debiais; Pascal Guggenbuhl; Christian Roux; Catherine Cormier; Bernard Cortet; Valérie Porquet-Bordes; Fabienne Coury; David Geneviève; Jean Chiesa; Thierry Colin; Elaine Fletcher; Agnès Guichet; Rose-Marie Javier; Michel Laroche; Michael Laurent; Ekkehart Lausch; Bruno LeHeup; Cédric Lukas; Georg Schwabe; Ineke van der Burgt; Christine Muti; Brigitte Simon-Bouy; Etienne Mornet
Journal:  J Bone Miner Metab       Date:  2017-12-13       Impact factor: 2.626

Review 4.  Dental manifestation and management of hypophosphatasia.

Authors:  Rena Okawa; Kazuhiko Nakano
Journal:  Jpn Dent Sci Rev       Date:  2022-07-02

5.  Deficiency of Mineralization-Regulating Transcription Factor Trps1 Compromises Quality of Dental Tissues and Increases Susceptibility to Dental Caries.

Authors:  Mairobys Socorro; Priyanka Hoskere; Catherine Roberts; Lyudmila Lukashova; Kostas Verdelis; Elia Beniash; Dobrawa Napierala
Journal:  Front Dent Med       Date:  2022-04-11

6.  Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism.

Authors:  M P Whyte; J D Mahuren; L A Vrabel; S P Coburn
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 7.  Hypophosphatasia.

Authors:  Etienne Mornet
Journal:  Orphanet J Rare Dis       Date:  2007-10-04       Impact factor: 4.123

8.  Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.

Authors:  Delphine Fauvert; Isabelle Brun-Heath; Anne-Sophie Lia-Baldini; Linda Bellazi; Agnès Taillandier; Jean-Louis Serre; Philippe de Mazancourt; Etienne Mornet
Journal:  BMC Med Genet       Date:  2009-06-06       Impact factor: 2.103

9.  Clinical, biochemical and genetic findings in adult patients with chronic hypophosphatasemia.

Authors:  V Guarnieri; F Sileri; R Indirli; G Guabello; M Longhi; G Dito; C Verdelli; S Corbetta
Journal:  J Endocrinol Invest       Date:  2021-07-02       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.